Abstract
According to the World Health Organization (WHO),[1] an estimated 1.28 billion adults worldwide aged 30–79 years had hypertension in 2021, two-third of whom were living in low- and middle-income countries. [...]the number of hypertensive patients is high, and many of them may choose to take treatment at home instead of hospitalization; and so, giving full consideration to the will of patients when forming recommendations is the key to promote the implementation of guidelines and improve patient compliance. [...]more attention needs to be paid to the composition of the working group of comprehensive hypertension guidelines in the future. [...]we assessed both methodological and reporting quality, while most of the existing studies on hypertension guidelines evaluation were restricted to the methodological quality without evaluating the reporting quality. [...]we conducted subgroup analyses according to the key information of the guidelines to evaluate the factors affecting the methodological and reporting quality from multiple perspectives.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Evidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu 730000, China
2 National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing 100037, China
3 School of Public Health, Lanzhou University, Lanzhou, Gansu 730000, China
4 The First School of Clinical Medicine, Lanzhou University, Lanzhou, Gansu 730000, China
5 Evidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu 730000, China; Research Unit of Evidence-Based Evaluation and Guidelines, Chinese Academy of Medical Sciences (2021RU017), School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu 730000, China; Lanzhou University Institute of Health Data Science, Lanzhou, Gansu 730000, China; Guideline and Standards Research Centre, Chinese Medical Association Publishing House, Beijing 100052, China; Lanzhou University GRADE Center, Lanzhou, Gansu 730000, China